Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis
Abstract Background Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in patients with cancer. Expert consensus recommends a risk‐based approach to guide prophylactic anticoagulation to prevent VTE in ambulatory patients with cancer receiving chemotherapy. However, oncology...
Main Authors: | Karlyn A. Martin, Rebecca Molsberry, Sadiya S. Khan, Jeffrey A. Linder, Kenzie A. Cameron, Al Benson III |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12431 |
Similar Items
-
Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
by: Nichole E. Brunton, et al.
Published: (2021-05-01) -
Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01) -
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia
by: Pasquale Madonna, et al.
Published: (2021-03-01) -
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01) -
Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
by: U Vasudeva Rao, et al.
Published: (2021-01-01)